Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models
- Patrick J. Roberts
- , Jerry E. Usary
- , David B. Darr
- , Patrick M. Dillon
- , Adam D. Pfefferle
- , Martin C. Whittle
- , James S. Duncan
- , Soren M. Johnson
- , Austin J. Combest
- , Jian Jin
- , William C. Zamboni
- , Gary L. Johnson
- , Charles M. Perou
- , Norman E. Sharpless
- University of North Carolina
- University of North Carolina at Chapel Hill
Research output: Contribution to journal › Article › peer-review
121
Scopus
citations